These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6094147)

  • 1. [Mechanisms of action and biochemical toxicology of valproic acid].
    Strolin Benedetti M; Rumigny JF; Dostert P
    Encephale; 1984; 10(4):177-88. PubMed ID: 6094147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinformatics analyses reveal GABAt and SSADH as major proteins involved in anticonvulsant activity of valproic acid.
    Piplani S; Verma PK; Kumar A
    Biomed Pharmacother; 2016 Jul; 81():402-410. PubMed ID: 27261619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid: metabolite concentrations in plasma and brain, anticonvulsant activity, and effects on GABA metabolism during subacute treatment in mice.
    Löscher W; Nau H
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):20-31. PubMed ID: 6810778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central actions of valproic acid in man and in experimental models of epilepsy.
    Hammond EJ; Wilder BJ; Bruni J
    Life Sci; 1981 Dec; 29(25):2561-74. PubMed ID: 6275228
    [No Abstract]   [Full Text] [Related]  

  • 6. [The neurotransmitter inhibitor GABA, the basis of the mechanism of action of several drugs affecting the central nervous system].
    Rodríguez-Trelles FA
    An R Acad Nac Med (Madr); 1984; 101(4):431-52. PubMed ID: 6152518
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valproic acid in cultured mammalian neurons.
    Buchhalter JR; Dichter MA
    Neurology; 1986 Feb; 36(2):259-62. PubMed ID: 3003620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.
    Luder AS; Parks JK; Frerman F; Parker WD
    J Clin Invest; 1990 Nov; 86(5):1574-81. PubMed ID: 2243131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.
    Tang W; Palaty J; Abbott FS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of an anticonvulsant, sodium dipropylacetate].
    Simler S; Ciesielski L; Klein M; Gobaille S; Mandel P
    C R Seances Soc Biol Fil; 1981; 175(1):114-9. PubMed ID: 6452931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of valproate: a commentatory.
    Johannessen CU
    Neurochem Int; 2000; 37(2-3):103-10. PubMed ID: 10812195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide.
    Hechler V; Ratomponirina C; Maitre M
    J Pharmacol Exp Ther; 1997 May; 281(2):753-60. PubMed ID: 9152382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study.
    Wang CC; Chen PS; Hsu CW; Wu SJ; Lin CT; Gean PW
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):111-20. PubMed ID: 22343008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice.
    Keane PE; Simiand J; Morre M
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):83-6. PubMed ID: 2859407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anticonvulsant drugs on brain amino acid metabolism.
    Chapman AG; Meldrum BS
    Prog Clin Biol Res; 1983; 124():63-76. PubMed ID: 6410409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Implications of GABAergic synapses in neuropsychiatry].
    Lloyd KG; Perrault G; Zivkovic B
    J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.